@prefix jvr: <http://data.loterre.fr/ark:/67375/JVR> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix mesh: <http://id.nlm.nih.gov/mesh/vocab#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .

jvr:-BT300B3G-Q
  skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-L6C0XPHT-4
  skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-XV06LPML-W
  skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-QP8Q6MQG-J
  skos:prefLabel "Association d'amlodipine et de valsartan"@fr, "Amlodipine, Valsartan Drug Combination"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:broader jvr:-XKXT5GBH-5 .

jvr:-FG8LP9J8-Q
  skos:prefLabel "Antihypertensive Agents"@en, "Antihypertenseurs"@fr ;
  a mesh:Descriptor, skos:Concept .

jvr:-Q3979798-W
  skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-H7K65Q8S-Z
  skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-TJHVZCRZ-0
  skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-G30ZJ446-J
  skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NFTHND7Q-8
  skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-FWD2BGQ0-9
  skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-THHNVC7V-3
  skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-R0ZCQ8X6-J
  skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-W8MNH2H7-8
  skos:prefLabel "Inhibiteurs des canaux calciques"@fr, "Calcium Channel Blockers"@en ;
  a mesh:Descriptor, skos:Concept .

jvr:-G4R176S9-J
  skos:prefLabel "analogs & derivatives (Qualifier)"@en, "analogues et dérivés (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-S0CS1X5R-5
  skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-M63HSDM7-1
  skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-HQRFT0C6-B
  skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-NB0XHT3S-N
  skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-W6SQV79N-S
  skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-CB30NGKB-3
  skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr: a skos:ConceptScheme .
jvr:-XKXT5GBH-5
  mesh:allowableQualifier jvr:-R3QWLHRG-V, jvr:-H7K65Q8S-Z, jvr:-THHNVC7V-3, jvr:-M63HSDM7-1, jvr:-D0F21513-5, jvr:-WK5F724J-1, jvr:-NHL3D2X0-S, jvr:-Q3979798-W, jvr:-NB0XHT3S-N, jvr:-G4R176S9-J, jvr:-NKM836P1-M, jvr:-G30ZJ446-J, jvr:-TJHVZCRZ-0, jvr:-L6C0XPHT-4, jvr:-SBNWSM1T-R, jvr:-NFTHND7Q-8, jvr:-T9HQD7ST-J, jvr:-S0CS1X5R-5, jvr:-BT300B3G-Q, jvr:-W6SQV79N-S, jvr:-HQRFT0C6-B, jvr:-XV06LPML-W, jvr:-FWD2BGQ0-9, jvr:-CB30NGKB-3, jvr:-R0ZCQ8X6-J ;
  skos:altLabel "103129-81-3"@fr, "103129-81-3"@en, "135877-50-8"@fr, "135877-50-8"@en, "CQ27G2BZJM"@fr, "CQ27G2BZJM"@en, "3,5-Pyridinedicarboxylic acid, 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl ester"@en, "3,5-Pyridinedicarboxylic acid, 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl ester"@fr, "135969-53-8"@fr, "135969-53-8"@en, "864V2Q084H"@fr, "864V2Q084H"@en, "103069-18-7"@fr, "103069-18-7"@en, "1J444QC288"@fr, "88150-42-9 (Amlodipine)"@fr, "88150-42-9 (Amlodipine)"@en, "1J444QC288"@en, "88150-47-4 (Amlodipine Maleate)"@fr, "88150-47-4 (Amlodipine Maleate)"@en, "111470-99-6 (Amlodipine Besylate)"@fr, "111470-99-6 (Amlodipine Besylate)"@en ;
  mesh:pharmacologicalAction jvr:-W8MNH2H7-8, jvr:-K9FBN5C5-1, jvr:-FG8LP9J8-Q ;
  skos:hiddenLabel "Amlodipine, (S)-Isomer, Maleate (1:1)"@en, "Amlodipine Maleate"@en, "Amlodipine, (R)-Isomer"@en, "Bésilate d'amlodipine"@fr, "Amlodipine Maleate (1:1)"@en, "Amlodipine, (+-)-Isomer, Maleate (1:1)"@en, "Amlodis"@en, "Norvasc"@en, "Amlodipine, (+-)-Isomer"@en, "Astudal"@en, "Bésylate d'amlodipine"@fr, "Amlodipine Besylate"@en, "Amlor"@en, "Istin"@en, "Maléate d'amlodipine"@fr ;
  skos:prefLabel "Amlodipine"@en, "Amlodipine"@fr ;
  skos:narrower jvr:-T56PX7GD-3, jvr:-QP8Q6MQG-J ;
  dc:established "1993-01-01"^^xsd:date ;
  skos:inScheme jvr: ;
  a skos:Concept, mesh:Descriptor ;
  dc:created "1992-05-07"^^xsd:date ;
  skos:broader jvr:-VJ4ZQC33-K ;
  owl:sameAs <http://id.nlm.nih.gov/mesh/D017311> ;
  dc:modified "2017-05-24"^^xsd:date ;
  skos:definition "A long-acting dihydropyridine calcium channel blocker. It is effective in the treatment of ANGINA PECTORIS and HYPERTENSION."@en .

jvr:-SBNWSM1T-R
  skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-VJ4ZQC33-K
  skos:prefLabel "Dihydropyridines"@en, "Dihydropyridines"@fr ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-XKXT5GBH-5 .

jvr:-K9FBN5C5-1
  skos:prefLabel "Vasodilator Agents"@en, "Vasodilatateurs"@fr ;
  a mesh:Descriptor, skos:Concept .

jvr:-D0F21513-5
  skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-R3QWLHRG-V
  skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NHL3D2X0-S
  skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-T9HQD7ST-J
  skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-T56PX7GD-3
  skos:prefLabel "Association de bésilate d'amlodipine et d'olmésartan médoxomil"@fr, "Amlodipine Besylate, Olmesartan Medoxomil Drug Combination"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:broader jvr:-XKXT5GBH-5 .

jvr:-NKM836P1-M
  skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-WK5F724J-1
  skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .